Expression of FAS within hypothalamic neurons: A model for decreased food intake after C75 treatment

American Journal of Physiology - Endocrinology and Metabolism

Volumn 283, Issue 5 46-5, 2002, Pages

  Kim, Eun Kyoung ^a   Miller, Ian ^a   Landree, Leslie E ^a   Borisy Rudin, Felice F ^a   Brown, Pierre ^a   Tihan, Tarik ^a   Townsend, Craig A ^b   Witters, Lee A ^c   Moran, Timothy H ^a   Kuhajda, Francis P ^a   Ronnett, Gabriele V ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Appetite; Feeding; Obesity

Indexed keywords

C 75; ENZYME INHIBITOR; FATTY ACID SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APPETITE; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; BRAIN REGION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; FLUORESCENCE; FOOD INTAKE; HYPOTHALAMUS; IMMUNOREACTIVITY; INNERVATION; MOUSE; NERVE CELL; NERVE ENDING; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TASTE AVERSION; THALAMUS MIDLINE NUCLEUS; WEIGHT GAIN;

EID: 0036841351     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00178.2002     Document Type: Article

References (74)

1. Abu-Elhiega L, Almarza-Ortega D, Baldini A, and Wakil S. Human acetyl-CoA carboxylase 2. Molecular cloning, characterization, chromosomal mapping, and evidence for two isoforms. J Biol Chem 272: 10669-10677, 1997.
2. Abu-Elhiega L, Jayakumar A, Baldini A, Chirala S, and Wakil S. Human acetyl-CoA carboxylase: Characterization, molecular cloning, and evidence for two isoforms. Proc Natl Acad Sci USA 92: 4011-1015, 1995.
3. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Fujimiya M, Katsuura G, Makino S, Fujino M, and Kasuga M. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 74: 143-147, 2001.
4. Asubel F, Brent R, Kingston R, Moore D, Seidman J, Smith J, and Struhl K. Current Protocols in Molecular Biology. New York: Wiley, 1998.
5. Banks W, Kastin A, Huang W, Jaspan J, and Maness L. Leptin enters the brain by a saturable system independent of insulin. Peptides 17: 305-311, 1996.
6. Baskin D, Figlewicz Lattemann D, Seeley R, Woods S, Porte DJ, and Schwartz M. Insulin and leptin: Dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res 848: 114-123, 1999.
7. Baura G, Foster D, Porte DJ, Kahn SE, Bergman R, Cobelli C, and Schwartz M. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest 92: 1824-1830, 1993.
8. Bianchi A, Evans J, Iverson A, Nordlund A, Watts T, and Witters L. Identification of an isozymic form of acetyl-CoA carboxylase. J Biol Chem 265: 1502-1509, 1990.
9. Breitschopf H, Suchanek G, Gould R, Colman D, and Lassmann H. In situ hybridization with digoxigenin-labeled probes: Sensitive and reliable detection method applied to myelinating rat brain. Acta Neuropathol (Berl) 84: 581-587, 1992.
10. Broberger C, De Lecea L, Sutcliffe J, and Hokfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 402: 460-474, 1998.
11. Broberger C, Johansen J, Johansson C, Schalling M, and Hokfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 95: 15043-15048, 1998.
12. Broberger C, Visser T, Kuhar M, and Hokfelt T. Neuropeptide Y innervation and neuropeptide-Y-Y1-receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse. Neuroendocrinology 70: 295-305, 1999.
13. Brown P and Molliver M. Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity. J Neurosci 20: 1952-1963, 2000.
14. Chronwall B, DiMaggio D, Massari V, Pickel V, Ruggiero D, and O'Donohue T. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 15: 1159-1181, 1985.
15. Cowley M, Pronchuk N, Fan W, Dinulescu D, Colmers W, and Cone R. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: Evidence of a cellular basis for the adipostat. Neuron 24: 155-163, 1999.
16. De Quidt M and Emson P. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. II. Immunohistochemical analysis. Neuroscience 18: 545-618, 1986.
17. Dickerson I, Dixon J, and Mains R. Transfected human neuropeptide Y cDNA expression in mouse pituitary cells. J Biol Chem 262: 13646-13653, 1987.
18. Drescher V, Chen H, and Romsos D. Corticotropin-releasing hormone decreases feeding, oxygen consumption and activity of genetically obese (ob/ob) and lean mice. J Nutr 124: 524-530, 1994.
19. Dube M, Kalra S, and Kalra P. Food intake elicited by central administration of orexins/hypocretins: Identification of hypothalamic sites of action. Brain Res 842: 473-477, 1999.
20. Edmond J, Robbins R, Bergstrom J, Cole R, and de Vellis J. Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res 18: 551-561, 1987.
21. Elias C, Aschkenasi C, Lee C, Kelly J, Ahima R, Bjorbaek C, Flier J, Saper C, and Elmquist J. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23: 775-786, 1999.
22. Elias C, Lee C, Kelly J, Aschkenasi C, Ahima R, Couceyro P, Kuhar M, Saper C, and Elmquist J. Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21: 1375-1385, 1998.
23. Elias C, Saper C, Maratos-Flier E, Tritos N, Lee C, Kelly J, Tatro J, Hoffman G, Ollmann M, Barsh G, Sakurai T, Yanagisawa M, and Elmquist J. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 402: 442-459, 1998.
24. Elmquist J, Elias C, and Saper C. From lesions to leptin: Hypothalamic control of food intake and body weight. Neuron 22: 221-232, 1999.
25. Elmquist J, Maratos-Flier E, Saper C, and Flier J. Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci 1: 445-450, 1998.
26. Evans J, Quistorff B, and Witters L. Zonation of hepatic lipogenic enzymes identified by dual digitonin pulse perfusion. Biochem J 259: 821-829, 1989.
27. Gabrielson E, Pinn M, Testa J, and Kuhajda F. Increased fatty acid synthase is a therapeutic target in mesothelioma. Clin Cancer Res 7: 153-157, 2001.
28. Guy J, Leclerc R, Baudry H, and Pelletier G. Identification of a second category of alpha-melanocyte-stimulating hormone (alpha-MSH) neurons in the rat hypothalamus. Brain Res 199: 135-146, 1980.
29. Hahn T, Breininger J, Baskin D, and Schwartz M. Coexpression of AGRP and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1: 271-272, 1998.
30. Heinrichs S, Menzaghi F, Pich E, Hauger R, and Koob G. Corticotropin releasing factor in the paraventricular nucleus modulates feeding induced by NPY. Brain Res 611: 18-24, 1993.
31. Kim T-S and Freake H. High carbohydrate diet and starvation regulate lipogenic mRNA in rats in a tissue-specific manner. J Nutr 126: 611-617, 1996.
32. Kopelman P. Obesity as a medical problem. Nature 404: 635-643, 2000.
33. Kow L and Pfaff D. The effects of the TRH metabolite cyclo(His-Pro) and its analogs on feeding. Pharmacol Biochem Behav 38: 359-364, 1991.
34. Koylu E, Couceyro P, Lambert P, and Kuhar M. Cocaine-and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J Comp Neurol 391: 115-132, 1998.
35. Koylu E, Couceyro P, Lambert P, Ling N, DeSouza E, and Kuhar M. Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland. J Neuroendocrinol 9: 823-833, 1997.
36. Kristensen P, Judge M, Thim L, Ribel U, Christjansen K, Wulff B, Clausen J, Jensen P, Madsen O, Vrang N, Larsen P, and Hastrup S. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393: 72-76, 1998.
37. Kuczmarski R. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys 1960 to 1991. JAMA 272: 205-211, 1994.
38. Kumar MV, Shimokawa T, Nagy TR, and Lane MD. Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice. Proc Natl Acad Sci USA 99: 1921-1925, 2002.
39. Kusakabe T, Maeda M, Hoshi N, Sugino T, Watanabe K, Kukuda T, and Suzuki T. Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells. J Histochem Cytochem 48: 613-622, 2000.
40. Lambert P, Couceyro P, McGirr K, Dall Vechia S, Smith Y, and Kuhar M. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 29: 293-298, 1998.
41. Levine A, Rogers B, Kneip J, Grace M, and Morley J. Effect of centrally administered corticotrophin releasing factor (CRF) on multiple feeding paradigms. Neuropharmacology 22: 337-339, 1983.
42. Li B, Xu B, Rowland N, and Kalra S. c-fos Expression in the rat brain following central administration of neuropeptide Y and effects of food consumption. Brain Res 665: 277-284, 1994.
43. Lin J-C. Monoclonal antibodies against myofibrillar components of rat skeletal muscle decorate the intermediate filaments of cultured cells. Proc Natl Acad Sci USA 78: 2331-2339, 1981.
44. Loftus T, Jaworsky D, Frehywot G, Townsend C, Ronnett G, Lane M, and Kuhajda F. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288: 2379-2381, 2000.
45. Maffei M, Halaas J, Ravussin E, Pratley R, Lee G, Zhang Y, Fei H, Kim S, Lallone R, and Ranganathan S. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 11: 1155-1161, 1995.
46. Momose K, Inui A, Asakawa A, Ueno N, Nakajima M, Fujimiya M, and Kasuga M. Intracerebroventricularly administered corticotropin-releasing factor inhibits food intake and produces anxiety-like behaviour at very low doses in mice. Diabetes Obes Metab 1: 281-284, 1999.
47. Nambu T, Sakurai T, Mizukami K, Hosova Y, Yanagisawa M, and Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res 827, 1999.
48. Ollmann M, Lamoreux M, Wilson B, and Barsh G. Interaction of agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes Dev 12: 216-330, 1998.
49. Olson B, Drutarosky M, Chow M, Hruby V, Stricker E, and Verbalis J. Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides 12: 113-118, 1991.
50. Paulauskis J and Sul H. Cloning and expression of mouse fatty acid synthase and other specific mRNAs. Developmental and hormonal regulation in 3T3-L1 cells. J Biol Chem 263: 7049-7054, 1988.
51. Paulauskis J and Sul H. Hormonal regulation of mouse fatty acid synthase gene transcription in liver. J Biol Chem 264: 574-577, 1989.
52. Pizer E, Wood F, Heine H, Romantsey F, Pasternack G, and Kuhajda F. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res 56: 1189-1193, 1996.
53. Qu D, Ludwig D, Gammeltoft S, Piper M, Pelleymounter M, Cullen M, Mathes W, Przypek R, Kanarek R, and Maratos-Flier E. A role for melanin-concentrating hormone in the central regulation of feeding behavior. Nature 380: 243-247, 1996.
54. Rossi M, Kim M, Morgan D, Small C, Edwards C, Sunter D, Abusnana S, Goldstone A, Russell S, Stanley S, Smith D, Yagaloff K, Ghatei M, and Bloom S. A C-terminal fragment of agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 139: 4428-4431, 1998.
55. Saha A, Vavvas D, Kurowski T, Apazidis A, Witters L, Shafrir E, and Ruderman N. Malonyl-CoA regulation in skeletal muscle: Its link to cell citrate and the glucose-fatty acid cycle. Am J Physiol Endocrinol Metab 272: E641-E648, 1997.
56. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli R, Tanaka H, Williams S, Richardson J, Kozlowski G, Wilson S, Arch J, Buckingham R, Haynes A, Carr S, Annan R, McNulty D, Liu W, Terrett J, Elshourbagy N, Bergsma D, and Yanagisawa M. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585, 1999.
57. Sawchenko P, Swanson L, Grzanna R, Howe P, Bloom S, and Polak J. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 241: 138-153, 1985.
58. Schwartz M, Woods S, Porte DJ, Seeley R, and Baskin D. Central nervous system control of food intake. Nature 404: 661-671, 2000.
59. Shimada M, Tritos N, Lowell B, Flier J, and Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396: 670-674, 1998.
60. Shimokawa T, Kumar MV, and Lane MD. Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides. Proc Natl Acad Sci USA 99: 66-71, 2002.
61. Soncini M, Yet S, Moon Y, Chun J, and Sul H. Hormonal and nutritional control of the fatty acid synthase promoter in transgenic mice. J Biol Chem 270: 30339-30343, 1995.
62. Spiegelman B and Flier J. Obesity and the regulation of energy balance. Cell 23:104: 531-543, 2001.
63. Spina M, Merlo-Pich E, Chan R, Basso A, Rivier J, Vale W, and Koob G. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273: 1561-1564, 1996.
64. Stanley B and Leibowitz S. Neuropeptide Y injected in the paraventricular hypothalamus: A powerful stimulant of feeding behavior. Proc Natl Acad Sci USA 82: 3940-3943, 1985.
65. Sul H and Wang D. Nutritional and hormonal regulation of enzymes in fat synthesis: Studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annu Rev Nutr 18: 331-351, 1998.
66. Swanson S, Foster D, McGarry J, and Brown N. Roles of the N- and C-terminal domains of carnitine palmitoyltransferase-1 isoforms in malonyl-CoA sensitivity of the enzymes: Insights from expression of chimaeric proteins and mutation of conserved histidine residues. Biochem J 335: 513-519, 1998.
67. Thupari JN, Landree LE, Ronnett GV, and Kuhajda FP. C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity. Proc Natl Acad Sci USA 11: 11, 2002.
68. Uehara Y, Shimizu H, Ohtani K, Sato N, and Mori M. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes 47: 890-893, 1998.
69. Vijayan E and McCann S. Suprression of feeding and drinking activity in rats following intraventricular injection of thyrotrophin releasing hormone (TRH). Endocrinology 100: 1727-1730, 1977.
70. Wellman P. Norepinephrine and the control of food intake. Nutrition 16: 837-842, 2000.
71. Wilding J, Gilbey S, Bailey C, Batt R, Williams G, Ghatei M, and Bloom S. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Neuroendocrinology 132: 1939-1944, 1993.
72. Woods S and Seeley R. Adiposity signals and the control ergy homeostasis. Nutrition 16: 894-902, 2000.
73. Woods S, Seeley R, Porte DJ, and Schwartz M. Signals that regulate food intake and energy homeostasis. Science 280: 1378- 1383, 1998.
74. Yannielli P and Harrington M. Neuropeptide Y in the mammalian circadian system: effects on light-induced circadian responses. Peptides 22: 547-556, 2001.